Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

NEOGAP Therapeutics AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 241 More Arrow 1,275 More Arrow 1,400
Earnings before taxes -11,444 Less Arrow -60,534 More Arrow -10,108
EBITDA -5,455 More Arrow -2,576 Less Arrow -8,970
Total assets 122,156 Less Arrow 63,571 More Arrow 124,454
Current assets 56,105 Less Arrow 25,054 More Arrow 49,348
Current liabilities 20,110 Less Arrow 4,099 More Arrow 4,448
Equity capital 48,547 Less Arrow 5,973 More Arrow 66,507
- share capital 133 Less Arrow 79 Less Arrow 50
Employees (average) 14 Equal arrow 14 Less Arrow 13

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 39.7% Less Arrow 9.4% More Arrow 53.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -9.2% Less Arrow -93.2% More Arrow -7.0%
Current ratio 279.0% More Arrow 611.2% More Arrow 1109.4%
Return on equity (ROE) -23.6% Less Arrow -1013.5% More Arrow -15.2%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 More Arrow 3
Chg. No. of employees % 0% More Arrow 8% More Arrow 30%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.